- 1) Jakubowski, J. A., and Maraganore, J. M., Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin. Blood, 75, 399-406 (1990).
- 2) Tsiang, M., Lentz, S. R., Dittman, W. A., Scarpati, E. M., and Sadler, J. E., Equilibrium binding of thrombin to recombinant human thrombomodulin: Effects of hirudin, fibrinogen, factor Va, and peptide analogues. Biochemistry, 29, 10602-10612 (1990).
- 3) Olson, S. T., Bjo, I., Sheffer, R., Craig, P. A., Shore, J. D., and Choay, J., Role of the antithrombin-binding pentasaccharides in heparin accerleration of antithrombin-proteinase reactions. J. Biol. Chem., 267, 12528-12538 (1992).
- 4) Strube, K.-H., Kroger, B., Bialojan, S., Otte, M., and Dodt, J., Isolation, sequence anlysis, and cloning of haemadin. J. Biol. Chem., 268, 8590-8595 (1993).
- 5) Friedrich, T., Kroger, B., Bialojan, S., Lemaire, H. G., Hoffken, H. W., Reuschenbach, P., Otte, M., and Dodt, J., A kazal-type inhibitor with thrombin specificity from Rhodnius prolixus. J. Biol. Chem., 268, 16216-16222 (1993).
- 6) Holsat, J., Lindblad, B., and Bergqvist, D., Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis-a comparison with low molecular weight heparin. Thromb. Haemost, 71, 214-219 (1994).
- 7) Rezaie, A. R., Cooper, S. T., Church, F. C., and Esmon, C. T., Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J. Biol. Chem., 270, 25336-25339 (1995).
- 8) Noeske-Jungblut, C., Haendler, B., Donner, P., Alagon, A., Possani, L., and Schleuning, W.-D., Triabin, a highly potent exosite inhibitor of thrombin. J. Biol. Chem., 270, 28629-28634 (1995).
- 9) Dahlback, B., and Stenflo, J., A natural anticoagulant pathway: biochemistry and physiology of protein C, S, C4b-binding protein and thrombomodulin. In “Haemostasis and Thrombosis” 3rd Ed., eds. Bloom, A. L., Forbes, C. D., and Thomas, D. P., London, Churchill livingstone, pp. 671-698 (1993).
- 10) Herbert, J. M., Herault, J. P., Bernat, A., van Amsterdam, R. G. M., lormeau, J. C., Petitou, M., van Boeckel, C., Hoffmann, P., and Meuleman, D. G., Biochemical and pharmacological properties of Sanorg 34006, a potent and long-acting synthetic pentasaccharide. Blood, 91, 4197-4205 (1998).
- 11) Kim, W., Choi, K., Kim, Y., Park, H., Choi, J., Lee, Y., Oh, H., Kwon, I., and Lee, S., Purification and characterization of a fibrinolytic enzyme produced from Bacillus sp. strain CK 11-4 screened from chungkook-jang. Appl. Environ. Microbiol., 62, 2482-2488 (1996).
- 12) Sumi, H., Hamada, H., Nakanishi, K., and Hiratani, H., Enhancement of the fibrinolytic activity in plasma by oral administration of NK. Acta Haematol., 84, 139-143 (1990).
- 13) Naski, M. C., Fenton II, J. W., Maraganore, J. M., Olson, S. T., and Shafer, J. A., The COOH-terminal domain of hirudin. J. Biol. Chem., 265, 13484-13489 (1990).
- 14) Choi, H. S., and Shin, H. H., Purification and characterization of a fibrinolytic protease in Pleurotus ostreatus. Mycologia, 90, 674-679 (1998).
- 15) Shin, H. H., and Choi, H. S., Purification and partial characterization of a metalloprotease in Flammulina velutipes. J. Microbiol., 36, 20-25 (1998).
- 16) Choi, H. S., and Sa, Y. S., Fibrinolytic and antithrombotic protease from Ganoderma lucidum. Mycologia, 92, 545-552 (2000).
- 17) Choi, H. S., and Sa, Y. S., Fibrinolytic and antithrombotic protease from Spirodela polyrhiza. Biosci. Biotechnol. Biochem., 65, 781-786 (2001).
Bioscience, Biotechnology, and Biochemistry
Volume 67, 2003 - Issue 4